Newly Established Specialty Pharmaceuticals Business Investment Opportunity in Tustin, USA
Pre-revenue pharmaceutical startup seeking funding to launch its cure for macular degeneration.
Premium Plan
| Established | 0-1 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Other |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Specialty Pharmaceuticals |
| Locations | Tustin |
| Local Time | 9:31 PM America / Chicago |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
15 million
for
33.0%
stake
(Native Currency: USD 15,000,000)
Reason: - Secure investment to hire contract manufacturers.
- Begin direct manufacturing of the product.
-...
View More
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Article Ready For Press Release
(1.1 MB)
5 Year Business Plan
(339.8 KB)
Business Overview
- The startup is in the pre-revenue stage.
- The business is not yet registered, and registration will be completed based on the investor’s choice and preferred country once funding is secured.
- The founder is currently based in Tustin, California.
- The founder has developed a pharmaceutical formula that stops the progression of vision loss caused by age-related macular degeneration (AMD) after years of research and development.
- Worldwide, there are approximately 400 million AMD sufferers.
- The medicine formula has been created, and the patent is currently in process.
- For major markets, the company plans to partner with a well-positioned pharmaceutical manufacturer, preferably one with existing eye-care products, for distribution.
- In less developed markets, distribution will be handled directly through professional networks and online sales programs, targeting patients and their physicians.
- The promoter has experience in founding and growing medical device and ophthalmic companies.
- He has led multiple mergers and acquisitions and developed innovative surgical and dental technologies, including intraocular lenses and fluidics-based devices.
- He is also actively engaged in pioneering research on age-related macular degeneration and non-surgical aesthetic medical procedures.
- The business is not yet registered, and registration will be completed based on the investor’s choice and preferred country once funding is secured.
- The founder is currently based in Tustin, California.
- The founder has developed a pharmaceutical formula that stops the progression of vision loss caused by age-related macular degeneration (AMD) after years of research and development.
- Worldwide, there are approximately 400 million AMD sufferers.
- The medicine formula has been created, and the patent is currently in process.
- For major markets, the company plans to partner with a well-positioned pharmaceutical manufacturer, preferably one with existing eye-care products, for distribution.
- In less developed markets, distribution will be handled directly through professional networks and online sales programs, targeting patients and their physicians.
- The promoter has experience in founding and growing medical device and ophthalmic companies.
- He has led multiple mergers and acquisitions and developed innovative surgical and dental technologies, including intraocular lenses and fluidics-based devices.
- He is also actively engaged in pioneering research on age-related macular degeneration and non-surgical aesthetic medical procedures.
Products & Services Overview
The company’s top-selling product will be its flagship pill formula that prevents vision loss from macular degeneration.
Assets Overview
- The business has no tangible assets.- Its intangible asset is the medicine formulation.
Facilities Overview
The business has not yet procured a facility. It will operate using contract manufacturers and warehouses. A separate office will be maintained for finance, sales, management, and order processing.
Capitalization Overview
The business is presently funded by the founder and inventor. He is the sole shareholder.
Recent Activity
-
1 week, 6 days agoDirector, Real Estate Consultancy And Investment, Lisbon, Corporate Investor / Buyer connected with the Business
-
2 weeks, 1 day agoCEO, Logistics, Obrenovac, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysBusiness Consultant & Advisor, Trading, Jakarta, Corporate Investor / Buyer connected with the Business
Tags:
Newly Established Specialty Pharmaceuticals Business Investment Opportunity in Tustin, USA
·Invest in Newly Established Specialty Pharmaceuticals Business in Tustin, USA
·Newly Established Specialty Pharmaceuticals Business Investment Opportunity
·Invest in Newly Established Specialty Pharmaceuticals Business
·Investment Opportunity in Tustin, USA
·Invest in Tustin, USA
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
2 Investors contacted this Business this month.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 64,000+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses